China & Medtronic

China: China highlighted regenerative agriculture partnerships and autonomous logistics solutions.

Medtronic: Medtronic demonstrated how AI is enabling digital healthcare, accelerating the deep fusion of the real economy with the digital economy.

China: CardioACC, one of the companies Medtronic invested in, is based in Shenzhen, China, and received approval for its ICE system from the China — National Medical Products Administration.

Medtronic: Medtronic made strategic investments in two privately held companies to enhance its cardiac ablation business and integrate intracardiac echocardiography (ICE) into its Affera mapping and ablation system, aiming to strengthen its leadership in electrophysiology.

China: China is among the countries facing potential 12.5% import taxes from the US due to an investigation into alleged forced labor, which could impact its trade relations.

Medtronic: Medtronic climbed after reporting a stronger profit and increasing its dividend payout, indicating positive financial performance.

Medtronic: Medtronic formed a strategic partnership with SOMNOmedics to integrate sleep monitoring data into its chronic disease digital health ecosystem.